Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

γδ T cells at the interface of innate and adaptive immunity in cancer.

Journal for immunotherapy of cancer·2026
Same author

A Case for Anti-IgE Vaccination.

Allergy·2026
Same author

Targeted Lymph Node Immunization with Serotype-Specific Dengue VLP Vaccines Enhances Antibody Avidity and Specificity.

Vaccines·2025
Same author

Versatile and Scalable Nanoparticle Vaccine as a Scaffold Against Newly Emerging Influenza Viruses.

Viruses·2025
Same author

The impact of viral evolution on vaccine development for SARS-CoV-2.

Current opinion in immunology·2025
Same author

A bacteriophage-based virus-like particle vaccine induces cross-reactive neutralising antibodies against porcine epidemic diarrhoea viruses (PEDV).

Veterinary research·2025

Related Experiment Video

Updated: Mar 7, 2026

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K

Harnessing Nanoparticles for Immunomodulation and Vaccines.

Ariane C Gomes1, Mona Mohsen2, Martin F Bachmann3,4

  • 1The Jenner Institute, Oxford University, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK. ariane.cruzgomes@ndm.ox.ac.uk.

Vaccines
|February 21, 2017
PubMed
Summary

Nanoparticles (NPs), especially virus-like particles (VLPs), have evolved significantly since their first vaccine application 40 years ago. These versatile nano-sized particles are now crucial in vaccine development as platforms, adjuvants, and drug delivery systems.

Keywords:
immunogennanoparticlesvaccinesvirus-like particles

More Related Videos

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
05:06

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy

Published on: November 10, 2023

1.6K
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.3K

Related Experiment Videos

Last Updated: Mar 7, 2026

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K
Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
05:06

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy

Published on: November 10, 2023

1.6K
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.3K

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Vaccinology

Background:

  • Nanoparticles (NPs) have a 40-year history in vaccination, starting with Hepatitis B vaccines.
  • The definition of NPs has broadened to include diverse engineered nano-sized materials.
  • Successful vaccines against Hepatitis B and Human Papilloma Virus (HPV) highlight NP technology's potential.

Purpose of the Study:

  • To review the applications of nanoparticles, particularly virus-like particles (VLPs), in vaccine development.
  • To discuss the multifaceted roles of NPs in modern vaccinology.

Main Methods:

  • Literature review focusing on nanoparticle applications in vaccines.
  • Analysis of NP roles as vaccines, antigen display platforms, adjuvants, and drug delivery systems.

Main Results:

  • Nanoparticles offer versatile applications beyond traditional vaccine roles.
  • Virus-like particles (VLPs) are a key type of NP with significant vaccine potential.
  • NPs serve as effective antigen display platforms, adjuvants, and drug delivery systems.

Conclusions:

  • Nanoparticle technology, especially VLPs, continues to be a vital and evolving area in vaccine research.
  • The versatility of NPs supports diverse strategies for enhancing vaccine efficacy and delivery.